| The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management MY Abou-Ismail, A Diamond, S Kapoor, Y Arafah, L Nayak Thrombosis research 194, 101-115, 2020 | 735 | 2020 |
| Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice G Zhou, A Hamik, L Nayak, H Tian, H Shi, Y Lu, N Sharma, X Liao, A Hale, ... The Journal of clinical investigation 122 (12), 4727-4731, 2012 | 245 | 2012 |
| KLF2 and KLF4 control endothelial identity and vascular integrity P Sangwung, G Zhou, L Nayak, ER Chan, S Kumar, DW Kang, R Zhang, ... JCI insight 2 (4), 2017 | 210 | 2017 |
| The role of neutrophils in thrombosis S Kapoor, A Opneja, L Nayak Thrombosis research 170, 87-96, 2018 | 183 | 2018 |
| “Go with the flow”: how Krüppel-like factor 2 regulates the vasoprotective effects of shear stress L Nayak, Z Lin, MK Jain Antioxidants & redox signaling 15 (5), 1449-1461, 2011 | 164 | 2011 |
| The myeloid transcription factor KLF2 regulates the host response to polymicrobial infection and endotoxic shock GH Mahabeleshwar, D Kawanami, N Sharma, Y Takami, G Zhou, H Shi, ... Immunity 34 (5), 715-728, 2011 | 163 | 2011 |
| Estrogen and thrombosis: a bench to bedside review MY Abou-Ismail, DC Sridhar, L Nayak Thrombosis research 192, 40-51, 2020 | 159 | 2020 |
| Factor XII and uPAR upregulate neutrophil functions to influence wound healing EX Stavrou, C Fang, KL Bane, AT Long, C Naudin, E Kucukal, A Gandhi, ... The Journal of clinical investigation 128 (3), 944-959, 2018 | 143 | 2018 |
| Kruppel-like factor 2 regulates endothelial barrier function Z Lin, V Natesan, H Shi, F Dong, D Kawanami, GH Mahabeleshwar, ... Arteriosclerosis, thrombosis, and vascular biology 30 (10), 1952-1959, 2010 | 126 | 2010 |
| Cancer-selective antiproliferative activity is a general property of some G-rich oligodeoxynucleotides EW Choi, LV Nayak, PJ Bates Nucleic acids research 38 (5), 1623-1635, 2010 | 109 | 2010 |
| Approach to chemotherapy-associated thrombosis P Oppelt, A Betbadal, L Nayak Vascular Medicine 20 (2), 153-161, 2015 | 89 | 2015 |
| Kruppel-like factor 2 is a transcriptional regulator of chronic and acute inflammation L Nayak, L Goduni, Y Takami, N Sharma, P Kapil, MK Jain, ... The American journal of pathology 182 (5), 1696-1704, 2013 | 72 | 2013 |
| Pulmonary thrombosis: a clinical pathological entity distinct from pulmonary embolism? F Marongiu, A Mameli, E Grandone, D Barcellona Seminars in Thrombosis and Hemostasis 45 (08), 778-783, 2019 | 65 | 2019 |
| G-rich oligonucleotides for cancer treatment PJ Bates, EW Choi, LV Nayak Gene Therapy of Cancer: Methods and Protocols, 379-392, 2009 | 52 | 2009 |
| KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression X Tang, P Wang, R Zhang, I Watanabe, E Chang, V Vinayachandran, ... The Journal of clinical investigation 132 (3), 2022 | 51 | 2022 |
| Leukocyte adhesion to P-selectin and the inhibitory role of Crizanlizumab in sickle cell disease: a standardized microfluidic assessment Y Man, U Goreke, E Kucukal, A Hill, R An, S Liu, A Bode, A Solis-Fuentes, ... Blood Cells, Molecules, and Diseases 83, 102424, 2020 | 47 | 2020 |
| The thromboprotective effect of bortezomib is dependent on the transcription factor Kruppel-like factor 2 (KLF2) L Nayak, H Shi, GB Atkins, Z Lin, AH Schmaier, MK Jain Blood, The Journal of the American Society of Hematology 123 (24), 3828-3831, 2014 | 47 | 2014 |
| Krüppel-like factors in endothelial cell biology E Chang, L Nayak, MK Jain Current opinion in hematology 24 (3), 224-229, 2017 | 43 | 2017 |
| A targetable pathway in neutrophils mitigates both arterial and venous thrombosis L Nayak, DR Sweet, A Thomas, SD Lapping, K Kalikasingh, A Madera, ... Science translational medicine 14 (660), eabj7465, 2022 | 34 | 2022 |
| An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1 Z Zheng, L Nayak, W Wang, A Yurdagul Jr, X Wang, B Cai, S Lapping, ... Blood, The Journal of the American Society of Hematology 133 (7), 743-753, 2019 | 31 | 2019 |
